| Literature DB >> 21305014 |
Matthew L Mayer1, Jared A Sheridan, Christoph J Blohmke, Stuart E Turvey, Robert E W Hancock.
Abstract
The discovery of novel antiinflammatory targets to treat inflammation in the cystic fibrosis (CF) lung stands to benefit patient populations suffering with this disease. The Pseudomonas aeruginosa quorum sensing autoinducer N-3-oxododecanoyl homoserine lactone (3O-C12) is an important bacterial virulence factor that has been reported to induce proinflammatory cytokine production from a variety of cell types. The goal of this study was to examine the ability of 3O-C12 to induce proinflammatory cytokine production in normal and CF bronchial epithelial cells, and better understand the cellular mechanisms by which this cytokine induction occurs. 3O-C12 was found to induce higher levels of IL-6 production in the CF cell lines IB3-1 and CuFi, compared to their corresponding control cell lines C38 and NuLi. Systems biology and network analysis revealed a high predominance of over-represented innate immune pathways bridged together by calcium-dependant transcription factors governing the transcriptional responses of A549 airway cells to stimulation with 3O-C12. Using calcium-flux assays, 3O-C12 was found to induce larger and more sustained increases in intracellular calcium in IB3-1 cells compared to C38, and blocking this calcium flux with BAPTA-AM reduced the production of IL-6 by IB3-1 to the levels produced by C38. These data suggest that 3O-C12 induces proinflammatory cytokine production in airway epithelial cells in a calcium-dependent manner, and that dysregulated calcium storage or signalling in CF cells results in an increased production of proinflammatory cytokines.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21305014 PMCID: PMC3031552 DOI: 10.1371/journal.pone.0016246
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1CF airway cells produce more IL-6 in response to 3O-C12.
Cytokine production was measured in supernatants from (A) CuFi and (B) IB3-1, or their matched non-CF counterparts 24 hr after treatment with 3O-C12 (100 µM). Bars show the mean of three independent experiments ± SEM; * p<0.05; ** p<0.01.
Pathway over-representation analysis of differentially expressed (DE) genes in A549 cells stimulated with 3O-C12 HSL.
| Pathway Name | Number of genes | Genes Ratio | p-value | |
| In pathway | DE in dataset | |||
| Gene expression of IL2 by AP-1 | 5 | 5 | 100% | 0.0007 |
| Activation of Chaperones by IRE1alpha | 4 | 3 | 75% | 0.0428 |
| Extrinsic prothrombin activation pathway | 13 | 6 | 46% | 0.0074 |
| Mets affect on macrophage differentiation | 18 | 8 | 44% | 0.0020 |
| TRAF6 Mediated Induction of the antiviral cytokine IFN-alpha/beta cascade | 18 | 7 | 39% | 0.0081 |
| Role of mitochondria in apoptotic signaling | 13 | 5 | 38% | 0.0431 |
| Intrinsic prothrombin activation pathway | 23 | 8 | 35% | 0.0069 |
| Toll Like Receptor 3 (TLR3) Cascade | 21 | 7 | 33% | 0.0180 |
| JNK cascade | 19 | 6 | 32% | 0.0427 |
| Canonical NF-kappaB pathway | 23 | 7 | 30% | 0.0276 |
| ATF-2 transcription factor network | 49 | 14 | 29% | 0.0006 |
| Calcium signaling in the CD4+ TCR pathway | 25 | 7 | 28% | 0.0407 |
| Calcineurin-regulated NFAT-dependent transcription in lymphocytes | 44 | 12 | 27% | 0.0027 |
| CD40/CD40L signaling | 30 | 8 | 27% | 0.0285 |
| NOD-like receptor signaling pathway | 62 | 15 | 24% | 0.0017 |
| IL12-mediated signaling events | 59 | 14 | 24% | 0.0028 |
| IL4 | 51 | 12 | 24% | 0.0077 |
| IL6-mediated signaling events | 45 | 11 | 24% | 0.0091 |
| P53 signaling pathway | 68 | 15 | 22% | 0.0033 |
| Regulation of Androgen receptor activity | 51 | 11 | 22% | 0.0238 |
| Glucocorticoid receptor regulatory network | 80 | 17 | 21% | 0.0024 |
| Direct p53 effectors | 135 | 26 | 19% | 0.0007 |
| NOTCH | 79 | 15 | 19% | 0.0121 |
| Small cell lung cancer | 84 | 15 | 18% | 0.0218 |
| TGF-beta signaling pathway | 86 | 15 | 17% | 0.0257 |
| Regulation of nuclear SMAD2/3 signaling | 82 | 14 | 17% | 0.0430 |
| T cell receptor signaling pathway | 83 | 14 | 17% | 0.0433 |
| TNFalpha | 189 | 31 | 16% | 0.0008 |
| Pathways in cancer | 325 | 41 | 13% | 0.0045 |
| MAPK signaling pathway | 270 | 32 | 12% | 0.0416 |
1. InnateDB pathway over-representation analysis tool; http://www.innatedb.ca.
2. Benjamini-Hochberg corrected p-value for multiple comparisons.
Gene ontology (GO) term over-representation analysis of differentially expressed (DE) genes in A549 cells stimulated with 3O-C12 HSL showing select1 terms pertaining to innate immunity and calcium signalling.
| GO term [ontology domain] | Number of genes | Genes Ratio | p-value | |
| In GO term | DE in dataset | |||
| calcineurin complex [cellular component] | 4 | 2 | 50% | 0.0189 |
| MAP kinase tyrosine/serine/threonine phosphatase activity [molecular function] | 13 | 6 | 46% | 4.69E-05 |
| cytokine production [biological process] | 10 | 3 | 30% | 0.0175 |
| response to calcium ion [biological process] | 27 | 5 | 19% | 0.0185 |
| cation transmembrane transporter activity [molecular function] | 41 | 6 | 15% | 0.0305 |
| inflammatory response [biological process] | 252 | 27 | 11% | 0.0017 |
| positive regulation of I-kappaB kinase/NF-kappaB cascade [biological process] | 112 | 12 | 11% | 0.0303 |
| innate immune response [biological process] | 606 | 58 | 10% | 0.0001 |
| cytokine activity [molecular function] | 191 | 19 | 10% | 0.0163 |
| transcription factor activity [molecular function] | 1050 | 98 | 9% | 2.39E-06 |
| metal ion binding [molecular function] | 2485 | 202 | 8% | 3.58E-07 |
1. Complete GO term over-representation analysis results can be found in Table S1.
2. Benjamini-Hochberg corrected p-value for multiple comparisons.
Figure 2Network analysis of transcriptional responses of A549 cells to 3O-C12 showing protein-protein interactions.
The color of gene nodes is proportional to their relative fold-change versus untreated cells, node-node connections represent known protein-level interactions annotated within InnateDB, and the node size reflects its degree of interconnectivity (hub-like nature) within the network.
Figure 33O-C12 triggers larger and more sustained rises in intracellular calcium in IB3-1 cells.
CF cell line IB3-1 and the isogenic CFTR-corrected cell line C38 were stimulated with 3O-C12 at (A) 100 µM or (B) 250 µM. Data are reported as Δ[Ca2+], the change in [Ca2+] in stimulated cells minus the change in vehicle treated cells. Data points show the mean of 6 replicate wells with serial measurements made every 50–60 s over 30 min. Graph is representative of one of three replicate experiments with similar results.
Figure 4Heightened induction of IL-6 in IB3-1 by 3O-C12 is antagonized by inhibiting intracellular calcium.
Cells were pre-treated for 1 hr with vehicle or BAPTA-AM (intracellular calcium chelator). Data points are the mean of three independent experiments ± SEM. Statistical significance for comparisons between vehicle and BAPTA-AM within a cell line are indicated with *; comparisons between IB3-1 (vehicle) and C38 (vehicle) are indicated with #; */# p<0.05; **/## p<0.01.